If
you missed...
“Patient Safety:
A
Quality System Approach to POCT QC/QA”
Presented by
Ellis Jacobs, Ph.D., DABCC, FACB
View the Slides I
Listen to the Recording
Summary:
The quality management system approach applies a
core set of “quality system essentials” to all
operations in any health care service’s path of
workflow. There are multiple QA issues with POCT and,
due to the rapid availability of results, POCT data can
be seen and acted upon prior to the application of QC
checks or other external mechanism for assuring the
validity of test results. The majority of errors in
POCT are pre-analytical in nature, followed by
post-analytical, with only 15% occurring during the
analytical phase. POCT technology has evolved to the
level of autonomation, intelligent automation that
detects single point failures and automatically stops
the analytical process. Never the less, QC procedures
are an essential part of the Quality Management System
and must be able to detect mistakes to enable immediate
correction. Surrogate and non-surrogate QC are not
completely redundant and do not detect all assay errors.
Objectives: After
this webinar, you will be able to:
-
To understand
what a Quality Management System is and what Quality
System Essentials are.
-
To be able to
describe the influence of POCT on the probability of
occurrence of pre-analytical, analytical and
post-analytical errors.
-
Understand the
nature of QC procedures and be able to describe the
differences between surrogate and non-surrogate
Quality Control.
-
To be able to
explain the critical factors to consider when
deciding the appropriate POCT QC system to
implement.
Vendor Sponsors:
Alere, Siemens, Accumetrics
About our
Speaker:
Ellis Jacobs is the Associate Professor of Pathology
at NYU School of Medicine and Director of Pathology at
Coler-Goldwater Memorial Hospital. Dr. Jacobs obtained
a B.S. degree in Chemistry and Natural Sciences from
Muhlenberg College in Allentown, PA, in 1974, and
received his Ph.D. in Biochemistry from the University
of South Carolina in 1979. He completed postdoctoral
training in Clinical Chemistry & Toxicology at the
University of North Carolina, Chapel Hill in 1981. He
joined the New York State (NYS) Department of Health (DOH)
as the Director of the Clinical Laboratory Evaluation
Program in 2002 and in 2005 was appointed Head of the
NYS DOH Therapeutic Substance Monitoring and Clinical &
Forensic Toxicology Proficiency Testing Programs, and
Head of the NYS DOH Limited Service Laboratory
Accreditation Program. He assumed his current positions
in 2008. For over twenty years Dr. Jacobs has been
involved in establishing clinical diagnostic regulatory
and accreditation standards at the local, national and
international levels. Dr. Jacobs is active in the
Clinical and Laboratory Standards Institute (CLSI) and
has been a advisor and member of the US Technical
Advisory Committee for ISO TC 212.
